VXUS vs. PBPH
VXUS (Vanguard Total International Stock ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both exchange-traded funds - VXUS is a Global Equities fund tracking the FTSE Global All Cap ex US Index, while PBPH is a Health & Biotech Equities fund tracking the BITA Global Pharma and Biotech Select Index. Both are passively managed. At a 0.39 correlation, their price movements are largely independent. VXUS charges 0.05%/yr vs 0.13%/yr for PBPH.
Performance
VXUS vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VXUS achieves a 12.51% return, which is significantly higher than PBPH's 2.63% return.
VXUS
- 1D
- -3.04%
- 1M
- 0.39%
- YTD
- 12.51%
- 6M
- 12.35%
- 1Y
- 29.41%
- 3Y*
- 18.90%
- 5Y*
- 8.35%
- 10Y*
- 10.23%
PBPH
- 1D
- 1.41%
- 1M
- 0.87%
- YTD
- 2.63%
- 6M
- 2.11%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
VXUS vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
VXUS Vanguard Total International Stock ETF | 12.51% | 4.91% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 2.63% | 0.74% |
Correlation
The correlation between VXUS and PBPH is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 25, 2025 | 0.39 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VXUS vs. PBPH — Risk / Return Rank
VXUS
PBPH
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
VXUS vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard Total International Stock ETF (VXUS) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VXUS | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.34 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 2.62 | — | — |
| Martin ratioReturn relative to average drawdown | 10.07 | — | — |
Loading charts...
Drawdowns
VXUS vs. PBPH - Drawdown Comparison
The maximum VXUS drawdown since its inception was -35.97%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for VXUS and PBPH.
Loading charts...
Drawdown Indicators
| VXUS | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.97% | -11.10% | -24.87% |
Max Drawdown (1Y)Largest decline over 1 year | -11.27% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -13.58% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -29.44% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | — | — |
Current DrawdownCurrent decline from peak | -3.04% | -5.21% | +2.17% |
Average DrawdownAverage peak-to-trough decline | -8.20% | -4.36% | -3.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.93% | — | — |
Volatility
VXUS vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| VXUS | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.07% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 14.44% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 16.36% | 17.07% | -0.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.27% | 17.07% | -0.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.03% | 17.07% | -0.04% |
VXUS vs. PBPH - Expense Ratio Comparison
VXUS has a 0.05% expense ratio, which is lower than PBPH's 0.13% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
VXUS vs. PBPH - Dividend Comparison
VXUS's dividend yield for the trailing twelve months is around 2.59%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VXUS Vanguard Total International Stock ETF | 2.59% | 3.18% | 3.37% | 3.24% | 3.09% | 3.10% | 2.14% | 3.06% | 3.18% | 2.73% | 2.93% | 2.83% |
Frequently Asked Questions
VXUS and PBPH have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, VXUS is cheaper at 0.05% per year. The better choice depends on whether you care most about return, fees, risk, or income.
VXUS is cheaper with a 0.05% expense ratio, compared with 0.13% for PBPH.
VXUS has the higher dividend yield at 2.59%, compared with 0.09% for PBPH.
VXUS is categorized as Global Equities, while PBPH is Health & Biotech Equities. VXUS tracks FTSE Global All Cap ex US Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: Vanguard and Portfolio Building Block. Their fees differ too: 0.05% for VXUS and 0.13% for PBPH.
Find the right allocation for VXUS and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer